Early Stage Venture Unlearn.AI Raises Series A of $3000000

November 5, 2020

About Unlearn.AI

Unlearn.AI develops a platform to accelerate clinical trials for Alzheimer’s Disease, Multiple Sclerosis, and other complex diseases.

Website: Learn more on Unlearn.AI’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Unlearn.AI

Amount Raised3000000 USD
Announced Date2020-11-05
Equity Only FundingYes
Organization LocationSan Francisco, California, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds2
Lead Investors
Number of Investors3
Number of Partner Investors